According to Wyoming State Pharmacy Law, a temporary pharmacist license shall not be effective for a period of more than three months from the date of issuance and shall not be renewed.
True or False
According to Wyoming State Pharmacy Law, a temporary pharmacist license shall not be effective for a period of more than three months from the date of issuance and shall not be renewed.
True or False
False, [Wyoming Pharmacy Act 33-24-134(e)].
The Board may issue a temporary pharmacist license according to Wyoming State Pharmacy Law. A temporary pharmacist license shall not be effective for a period of more than six (6) months from the date of issuance and shall not be renewed.
If the prescription is dispensed by an intern, which of the following shall be placed on the label of dispensing container?
I. An initial of dispensing pharmacist.
II. An initial of intern.
III. An initial of preceptor.
a. II only
b. II and III only
c. III only
d. All
Answer:
If the prescription is dispensed by an intern, which of the following shall be placed on the label of dispensing container?
I. An initial of dispensing pharmacist.
II. An initial of intern.
III. An initial of preceptor.
a. II only
b. II and III only
c. III only
d. All
Answer: An initial of preceptor is required, [Wyoming Pharmacy Act, 33-24-136(a)].
(a). Every person who prepares, compounds, processes, packages or repackages, dispenses, fills or sells or offers for sale, at retail or in connection with operation of a health care facility, any prescription, shall place the written memorandum of the prescription in a separate file marked and kept for that purpose, and shall affix a label to the container in which the prescribed substance is dispensed bearing
a. the name and address of the pharmacy and initials of the dispensing pharmacist,
OR
b. of the preceptor if the dispenser is an intern,
c. the date on which the prescription is filed in the pharmacy's files,
d. the name of the person who prescribed the substance,
e. the name of the patient or customer for whom the prescription was made and
f. directions for use by the patient as directed on the prescription by the prescriber.
Drug Enforcement Administration (DEA) has published its final rule rescheduling hydrocodone combination products from Schedule III to Schedule II in the Federal Register.
The change imposes Schedule II regulatory controls and sanctions on anyone handling hydrocodone combination products, effective October 6, 2014. DEA first published the proposed rules in March 2014, in response to a Food and Drug Administration recommendation.
DEA received almost 600 public comments regarding the proposed rules after they were published, with a small majority of the commenters supporting the change, a DEA press release notes.
Drug Enforcement Administration (DEA) has published its final rule rescheduling hydrocodone combination products from Schedule III to Schedule II in the Federal Register.
The change imposes Schedule II regulatory controls and sanctions on anyone handling hydrocodone combination products, effective October 6, 2014. DEA first published the proposed rules in March 2014, in response to a Food and Drug Administration recommendation.
DEA received almost 600 public comments regarding the proposed rules after they were published, with a small majority of the commenters supporting the change, a DEA press release notes.
Under the Utah State Pharmacy Law, a pharmacy technician may retrieve a new prescription drug order from a voicemail if he/she keeps voicemail order for a pharmacist to review later.
True or False
Under the Utah State Pharmacy Law, a pharmacy technician may retrieve a new prescription drug order from a voicemail if he/she keeps voicemail order for a pharmacist to review later.
Answer: True, [Utah Pharmacy Practice Act Rule R156-17b-601(1)(K)]. The pharmacy technician may retrieve a new prescription drug order from the voicemail if he/she keeps the voicemail order for a pharmacist to review it later.
A pharmacy located in Utah that is authorized to provide pharmaceutical care for patients in an institutional setting and whose primary purpose is to provide a physical environment for patients to obtain health care services is classified as:
a. Class A Pharmacy
b. Class B Pharmacy
c. Class C Pharmacy
d. Class D Pharmacy
A pharmacy located in Utah that is authorized to provide pharmaceutical care for patients in an institutional setting and whose primary purpose is to provide a physical environment for patients to obtain health care services is classified as:
a. Class A Pharmacy
b. Class B Pharmacy
c. Class C Pharmacy
d. Class D Pharmacy
Answer: (b) Class B Pharmacy, [Utah Pharmacy Practice Act 58-17b-102 Definition: 11].
Class A Pharmacy: Means a pharmacy located in Utah that is authorized as a retail pharmacy to compound or dispense a drug or dispense a device to the public under a prescription order.
Class B Pharmacy: Means a pharmacy located in Utah that is authorized to provide pharmaceutical care for patients in an institutional setting and whose primary purpose is to provide a physical environment for patients to obtain health care services. It includes closed-door, hospital, clinic, nuclear, and branch pharmacies; and pharmaceutical administration and sterile product preparation facilities.
Class C Pharmacy: Means a pharmacy that engages in the manufacture, production, wholesale, or distribution of drugs or devices in Utah.
Class D pharmacy: Means a nonresident pharmacy.
Class E pharmacy: Means all other pharmacies.
Closed-door pharmacy: Means a pharmacy that provides pharmaceutical care to a defined and exclusive group of patients who have access to the services of the pharmacy because they are treated by or have an affiliation with a specific entity, including a health maintenance organization or an infusion company, but not including a hospital pharmacy, a retailer of goods to the general public, or the office of a practitioner.
Where no pharmacist is present in the professional service area a pharmacy is not required to convert to a non−prescription or sundry outlet if the:
I. The pharmacist is absent for a time period of one half hour or less.
II. The pharmacist must be accessible for communication with the remaining pharmacy staff by phone, pager or other device.
III. The pharmacy must indicate that the pharmacist is not available in the professional service area and indicate the period of absence and the time of the pharmacist's return.
a. I only
b. I and II only
c. II and III only
d. All
Where no pharmacist is present in the professional service area a pharmacy is not required to convert to a non−prescription or sundry outlet if the:
I. The pharmacist is absent for a time period of one half hour or less.
II. The pharmacist must be accessible for communication with the remaining pharmacy staff by phone, pager or other device.
III. The pharmacy must indicate that the pharmacist is not available in the professional service area and indicate the period of absence and the time of the pharmacist's return.
a. I only
b. I and II only
c. II and III only
d. All
Answer: All, [Wisconsin Administrative Code Chapter-6 Phar-6.04(3)(c)].
(c). Where no pharmacist is present in the professional service area a pharmacy is not required to convert to a non−prescription or sundry outlet if the following requirements are met:
1. The pharmacist is absent for a time period of one half hour or less.
2. The pharmacist must be accessible for communication with the remaining pharmacy staff by phone, pager or other device.
3. The pharmacy must indicate that the pharmacist is not available in the professional service area and indicate the period of absence and the time of the pharmacist's return.
4. Pharmacy technicians may only perform duties allowed by s. Phar 7.015 (2).
a. A pharmacy license authorizes a pharmacy to operate only at the location designated on the license. Licenses may not be transferred to another location.
b. A hospital which has a pharmacy area providing outpatient pharmacy services which is physically separate from, and not contiguous to the area from which inpatient pharmacy services are provided, shall have a pharmacy license for the outpatient phamacy in addition to a license for the inpatient pharmacy.
Any change in pharmacy ownership shall be reported to the board office and the pharmacy license of the former owner returned. A pharmacy license shall be granted to the new pharmacy.
Which of the following information about the Ebola virus is/are TRUE?
I. There's no cure or vaccine for Ebola.
II. Ebola wreaks life-threatening havoc within the body by attacking multiple organ systems at the same time.
III. Experts stress that early and intense medical care can greatly improve a person's chances of survival.
a. I only
b. I and II only
c. II and III only
d. All
Which of the following information about the Ebola virus is/are TRUE?
I. There's no cure or vaccine for Ebola.
II. Ebola wreaks life-threatening havoc within the body by attacking multiple organ systems at the same time.
III. Experts stress that early and intense medical care can greatly improve a person's chances of survival.
a. I only
b. I and II only
c. II and III only
d. All
Answer: (d), All. The Ebola virus currently raging in West Africa has a well-earned reputation as one of the world's most deadly illnesses. But experts stress that early and intense medical care can greatly improve a person's chances of survival.
There's no cure or vaccine for Ebola, which wreaks life-threatening havoc within the body by attacking multiple organ systems at the same time.
Instead, doctors must fall back on the basics of "good meticulous intensive care," supporting the patient and targeting treatment toward the organs that are under attack by the virus.
The virus is particularly tough to combat because once it gets into the human body, it attacks so many different tissues. In contrast, most viruses tend to target one specific organ. For example, influenza goes after the respiratory system.
Ebola attacks every organ system, including the heart, lungs, brain, liver and kidneys. It even attacks a person's blood, thinning it and causing Ebola's trademark bleeding from multiple orifices.
Who shall establish and maintain a PMP program to monitor the prescribing and dispensing of all Schedule II, III, IV and V controlled substances by prescribers in Delaware?
a. The Office of Controlled Substances
b. The Delaware State Pharmacy Board
c. Bureau of Narcotics and Dangerous Drugs
d. ISMP
Who shall establish and maintain a PMP program to monitor the prescribing and dispensing of all Schedule II, III, IV and V controlled substances by prescribers in Delaware?
a. The Office of Controlled Substances
b. The Delaware State Pharmacy Board
c. Bureau of Narcotics and Dangerous Drugs
d. ISMP
Answer: (a), The Office of Controlled Substances, [Uniform Controlled Substances Act 16-47-4798(c)].
The Office of Controlled Substances shall establish and maintain a PMP program to monitor the prescribing and dispensing of all Schedule II, III, IV and V controlled substances by prescribers in this State, and to research the prescribing and dispensing of drugs of concern. The PMP shall not interfere with the legal use of a controlled substance or drug of concern. The PMP shall be:
(1). Used to provide information to prescribers, dispensers, and patients to help avoid the illegal use of controlled substances;
(2). Used to assist law enforcement to investigate illegal activity related to the prescribing, dispensing and consumption of controlled substances or drugs of concern; and
(3). Designed to minimize inconvenience to patients and prescribing medical practitioners while effectuating the collection and storage of prescription monitoring information.
